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ABSTRACT 
Tuberculosis (TB) is caused by Mycobacterium tuberculosis and the most important public health problem in the world. In 2012, 
there were an estimated 8.6 million incident cases of TB globally, and estimeated 67,000 deaths among TB cases in 2012.  
Indonesia ranks 4th  on the list of TB high burden countries in the world with 450,000 cases,  estimated cases of MDR TB were 
5700 and 65.000 deaths among TB cases in Indonesia, 2011.This research was conducted to isolate and characterize of seagrass 
Enhalus sp. -associated bacteria that having antimycobacterial activity against multi drug resistant tuberculosis bacteria.   There 
were 9 isolates collected from Enhalus sp. One isolate from Enhalus sp.-associated bacteria were successfully screened for 
antimycobacterial against tuberculosis bacteria. EKJP9 was found to inhibit the growth of tuberculosis bacteria (MDR TB strain 
HE , SR, HR). Based on DNA Data Bank of Japan the accession number of EKJP9 is AB851799. It is Bacillus sp. 
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1.Introduction 
Tuberculosis (TB) remains a major global health problem. The disease is spread in the air. In general, 
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people infected with Mycobacterium tuberculosis will develop TB disease which increase the numbers of infected 
people moving into the community and thus expose the general population to the risk of contracting a resistant strain 
of infection. In 2012, there were an estimated 8.6 million incident cases of TB globally,equivalent to  185 cases per 
100,000 population, And estimated 67,000 deaths among TB cases. Indonesia ranks 4th on the list of TB high burden 
countries in the world.   It is estimated that total cases of TB were 460,000, and  cases deaths were 67,000 [1]. 
Today some strains of bacterial infections are treatable with only a single drug; some no longer have effective 
treatments. Infections caused by resistant microbes may fail to respond to treatment, resulting in prolonged illness 
and greater risk of death. The past 20 years have seen the worldwide appearance of multidrug-resistant (MDR) TB. 
MDR TB is caused by Mycobacterium tuberculosis that is resistant at least to isoniazid and rifampicin, the most 
effective anti-TB drugs. These drugs are considered first-line drugs and are used to treat all persons with TB disease 
[2]. Globally in 2012, there were an estimated 450,000 cases of MDR TB in the world and  estimated cases MDR 
TB  in Indonesia were 5,700[1]. 
 
The oceans, with their unique and wide range of biodiversity, producing unusual metabolites, emerges as a 
good candidate for new antimycobacterial agents. The development of marine organisms-derived compounds into 
drugs has been held back by supply limitations. Several marine organisms have adapted themselves through 
symbiotic association among themselves that help them survive under harsh environments. Symbioses between 
microorganisms and marine organisms are abundant and widespread in the sea. Most marine invertebrates and algae 
harbor diverse microbial symbionts including prokaryotic bacteria, archaea, cyanobacteria, and fungi. Increasing 
evidence implicates microbial symbionts as the true source of many marine organism-derived compounds, which 
makes marine microbial symbionts a hotspot in the field of marine microbiology and marine natural products 
because of their potential for solving the bottleneck problem of marine natural product supply[2] Although marine 
microorganisms are not well defined taxonomically, preliminary studies in this field unequivocally indicate that the 
wealth of microbial diversity in the world’s oceans, coupled with its biochemical uniqueness, make this a promising 
frontier for the discovery of new medicines[3]. Appear of resistant TB drugs need a new antibiotic alternative to 
richness the kind of TB drugs. On the other side Indonesia has biodiversity in ocean that needs to know it’s big 
potentially, so we were very interest to know the antimycobacterial activity from sea grass Enhalus sp. associated 
bacteria against Multi Drug Resistant Tuberculosis bacteria. The research purpose was to isolate and characterize of 
seagrass Enhalus sp. -associated bacteria that having antimycobacterial activity against multi drug resistant 
tuberculosis bacteria. 
 
2. Material and Method 
The study was conducted at  Karimunjawa-Jepara,North Java Sea Indonesia.  Sea grass Enhalus sp. were 
put into sterile plastic bags (Whirl-Pak, Nasco USA). The tissue were rinsed with sterile seawater and  homogenized 
with  blender. The homogenized tissue were serially diluted, spread on half strength ZoBell 2216E marine agar 
medium and incubated at room temperature for 2x24 hours.  On the basis of morphological features colonies were 
randomly picked and purified by making streak plates[4]. 
 
2.1. Antibacterial test 
Antibacterial test of Enhalus sp. associated bacteria against MDR TB bacteria was performed by using an 
overlay and dilution method. MDR TB bacteria (MDR TB strain HE resistant to Isoniazid and Ethambutol,strain SR 
resistant to Streptomycin and Rifampicin, and strain HR resistant to Isoniazid and Rifampicin) used in this study 
were obtained from Health Laboratory Of Center of Java Provence-Semarang. Culture of each bacterium in the 
logarithmic phase was mixed with Middle brook 7H9+OADC soft agar medium (1% v/v), which were poured on to 
the respective agar surface previously inoculated with Enhalus sp. associated bacteria that had incubated for 4 days 
at room temperature. Then the plates were incubated at room temperature 2x24 hours.  Antibacterial activity was 
defined by the formation of inhibition zones around the MDR TB bacterial colonies and the minimum inhibitory 
concentration of extract EKJP9 at 25%, 50%,75% and 100%. 
 
2.2.PCR amplification and DNA sequencing 
PCR amplification was carried out according to the method of Radjasa et al (2007). Universal primers described by 
Weisburg et al (1991) was used for PCR amplification. Genomic DNA of strains for PCR analysis were obtained 
from cell materials taken from an agar plate, suspended in sterile water (Sigma, Germany) and subjected to five 
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cycles of freeze (-80oC) and thaw (95 oC).  PCR amplification or partial 16S rRNA gene of Enhalus sp. associated 
bacteria and subsequent sequencing analysis were performed according to method of Radjasa et al (2007)[5].  The 
determined DNA sequences of strains were compared for homology to the BLAST database. 
 
3. Results and Discussion 
There were nine isolates association bacteria from sea grass Enhalus sp. The morphology identification 
shown in Table 1. 
Tabel 1. Morphology Identification of Enhalus sp. Assosiated Bacteria 
Sample No. Code of bacteria Type of biota Shape Colour Textur 
47 
48 
49 
50 
51 
52 
53 
54 
55 
EKJP1 
EKJP2 
EKJP3 
EKJP4 
EKJP5 
EKJP6 
EKJP7 
EKJP8 
EKJP9 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Enhalus 
Round 
Round 
Round 
Oval 
Oval 
Round 
Round 
Round 
Little Round 
Brown 
Yellow 
White 
White 
Yellow 
White 
Brown 
Transparant 
Yellow 
Convex 
Convex 
Rough 
Smooth 
Convex 
Rough 
Convex 
Rough 
Rough 
 
Only one isolate association bacteria were found to inhibit the growth of MDR TB bacteria (MDR TB 
strain HE,strain SR, and strain HR) as shown in Table 2. 
 
Table 2. Inhibit zone from EKJP9 against MDR TB  
No. Isolate Inhibit zone (cm) 
1 
2 
3 
No 55 EKJP9  to MDR TB HE 
No 55 EKJP9  to MDR TB SR 
No 55 EKJP9 to  MDR TB HR 
0.390 
0.240 
0.330 
 
Multi drugs resistant tuberculosis (MDR TB) that used for this research were MDR TB strain HE 
(Mycobacterium tuberculosis resistant Isoniazid and Etambutol), MDR TB strain SR (Mycobacterium tuberculosis 
resistant Streptomycin and Rifampicin), MDR TB strain HR (Mycobacterium tuberculosis resistant Isoniazid and 
Rifampicin). Isoniazid, Rifampicin, Etambutol and Streptomycin are the first line drugs for tuberculosis. The Sea 
grass, Enhalus sp. associated bacteria EKJP9 had potential antibacterial activities. Their potential antibacterial were 
from secondary metabolites microorganism that produced when bacteria cell finished the logarithmic phase and 
going into stationer phase. This phase is called “idiophase”. Secondary metabolite  microorganism can come from 
the conversion of primary metabolites[6].  
 
 
Fig 1. Inhibit the growth of MDR TB HE 
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Fig 2. Inhibit the growth of MDR TB SR 
 
 
Fig 3. Inhibit the growth of MDR TB HR 
 
The previous study showed that associated bacteria from soft coral Sinularia sp. exhibited secondary 
metabolite producing marine bacteria with antibacterial activity that potential against tuberculosis bacteria: 
Mycobacterium tuberculosis H37Rv and the resistant strains: MDR TB strain HE  and MDR TB strain SR[7]. 
  
Table 3. Turbidity level at variation contration of extract EKJP9 
to MDR TB HE 
Incubation 
(hours) 
Concentration of extract EKJP9(%) 
100 75 50 25 0 Control 
0 1744 1.600 1.254 0.592 0.018 0.027 
24 2.080 2.024 1.761 1.295 0.920 1.011 
48 1.862 1.716 1.570 1.991 1.237 1.690 
 
Minimum turbidity from table 3 was 0.018 at 0% concentration of extract EKJP9 and the maximum was 2.080 at 
100% concentration of extract EKJP9. There were turbidity decrease from 50%, 75% until 100% concentration of 
extract EKJP9. 
 
Table 4. Turbidity level at variation contration of extract EKJP9 
to MDR TB HR 
Incubation 
(hours) 
Concentration of extract EKJP9(%) 
100 75 50 25 0 control 
0 1.910 1.649 1.428 0.873 0.076 0.139 
24 1.922 1.714 1.578 1.219 0.606 0.853 
48 1.748 1.237 1.270 1.156 0.842 1.210 
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Minimum turbidity from table 4 was 0.076  at 0% concentration of extract EKJP9 and the maximum was 1.922 at 
75% concentration of extract EKJP9. There were turbidity decrease from 25%, 50%, 75% until 100% concentration 
of extract EKJP9. 
 
Table 5. Turbidity level at variation contration of extract EKJP9 
to MDR TB SR 
Incubation 
(hours) 
Concentration of extract EKJP9(%) 
100 75 50 25 0 control 
0 1.748 1.539 1.320 0.784 0.030 0.024 
24 1.874 1.792 1.648 1.372 0.718 0.460 
48 1.730 1.433 1.384 1.551 1.280 0.764 
 
Minimum turbidity from table 5 was 0.024 at control concentration of extract EKJP9 and the maximum was 1.874 at 
100% concentration of extract EKJP9. There were turbidity decrease from 50%, 75% until 100% concentration of 
extract EKJP9. 
 
The minimum inhibitory concentration of EKJP9 extracts that can inhibit the growth of MDR TB bacteria 
was the concentration of 75%, because there were no difference between the minimum inhibitory concentration of 
EKJP9 extract concentration 75% to 100% concentration. Extraction was done in this study still produces many 
compounds, it was not  pure compounds. The compounds such as alkaloids, saponins and triterpenoids. The 
mechanisms involved in inhibiting the growth of MDR TB bacteria can not be known, whether the mechanism of 
the synergism of the various chemical constituents from many compounds, or only one of the activities of the 
chemical constituents. 
 
Isolate  EKJP 9 Complete sequence (1272 nukleotida) 
 
 
 
 
 
 
 
 
 
Fig 4. Complete Sequence of EKJP9 
 
 
Sequencing of the 16S rRNA gene is presently the most commonly used molecular approach in bacterial 
phylogeny (Woese et al., 1990). Using this methodology, The EKJP9 isolate was Bacillus sp., as the accession 
number AB851799 from the DNA Data Bank of Japan. The confrontation test showed that the isolate produced 
active substances, the active substances could be antibiotics since most natural antimicrobial agents of bacterial 
origin are mainly synthesized by Bacillus and actinomycetes[8]. The accesion number of EKJP9 is AB851799 from 
the DNA Data Bank of Japan (DDBJ).  
 aacctgcctg taagactggg ataactccgg gaaaccggag ctaataccgg atagttcctt gaaccgcatg gttcaaggat gaaagacggt ttcggctgtc 
acttacagat ggacccgcgg cgcattagct agttggtgag gtaacggctc accaaggcga cgatgcgtag ccgacctgag agggtgatcg gccacactgg 
gactgagaca cggcccagac tcctacggga ggcagcagta gggaatcttc cgcaatggac gaaagtctga cggagcaacg ccgcgtgagt gatgaaggtt    
ttcggatcgt aaagctctgt tgttagggaa gaacaagtgc aagagtaact gcttgcacct tgacggtacc taaccagaaa gccacggcta actacgtgcc 
agcagccgcg gtaatacgta ggtggcaagc gttgtccgga attattgggc gtaaagggct cgcaggcggt ttcttaagtc tgatgtgaaa gcccccggct 
caaccgggga gggtcattgg aaactgggaa acttgagtgc agaagaggag agtggaattc cacgtgtagc ggtgaaatgc gtagagatgt ggaggaacac       
cagtggcgaa ggcgactctc tggtctgtaa ctgacgctga ggagcgaaag cgtggggagc gaacaggatt agataccctg gtagtccacg ccgtaaacga 
tgagtgctaa gtgttagggg gtttccgccc cttagtgctg cagctaacgc attaagcact ccgcctgggg agtacggtcg  caagactgaa actcaaagga 
attgacgggg gcccgcacaa gcggtggagc atgtggttta attcgaagca acgcgaagaa ccttaccagg tcttgacatc ctctgacaac cctagagata     
gggctttccc ttcggggaca gagtgacagg tggtgcatgg ttgtcgtcag ctcgtgtcgt gagatgttgg gttaagtccc gcaacgagcg caacccttga 
tcttagttgc cagcattcag ttgggcactc taaggtgact gccggtgaca aaccggagga aggtggggat gacgtcaaat catcatgccc cttatgacct 
gggctacaca cgtgctacaa tggacagaac aaagggctgc gagaccgcaa ggtttagcca atcccacaaa tctgttctca gttcggatcg cagtctgcaa     
ctcgactgcg tgaagctgga atcgctagta atcgcggatc agcatgccgc ggtgaatacg  ttcccgggcc tt 
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Fig 4. Molecular Phylogenetic analysis by Maximum Likelihood method 
 
Recently, the systematic of the Bacillus group has been widely modified. Few publications are devoted to 
the study of the Bacillus species isolated from the marine environment. Due to their ubiquity and capability to 
survive under adverse conditions, heterotrophic Bacillus strains are hardly considered to be species of certain 
habitats. Species of B. marinus, B. badius B. subtilis, B. cereus, B. licheniformis, B. firmus,and B. lentus were often 
isolated from marine habitats. The marine bacilli showed that strains of B. marinus, B. subtilis, B. pumilus, B. 
licheniformis, B.cereus, and B. mycoides are common inhabitants of the Pacific Ocean habitat. A group of marine 
Bacillus strains from the Collection of Marine Microorganisms (KMM) of the Pacific Institute of Bioorganic 
Chemistry (Vladivostok, Russia) has been taxonomically studied in view of their ability to produce biologically 
active compounds. One isolate, KMM 1717, associated with a sponge from the Coral Sea was identified as B. 
pumilus. Two strains, Bacillus KMM 1916 and KMM 1918, showed antibiotic sensitivity profiles similar to B. 
licheniformis, but they had a distinct fatty acid composition and peculiar phenotypic traits. A few bacilli of marine 
origin have been reported to produce unusual metabolites different from those isolated from terrestrial bacteria. 
These metabolites include an antibiotic, 3-amino-3-deoxy-D-glucose, a new glucanase, and cyclic acylpeptides [9]. 
 
Bacillus is a  gram positive bacteria with rod shaped  and a member of the division Firmicutes. Bacillus 
species can be obligate aerob or facultative anaerob, and test positive for the  catalase enzyme. Ubiquitous in nature, 
Bacillus includes both free-living and pathogenic species[4]. 
 
The number of antibiotics produced by genus Bacillus was 167. These antibiotics are mainly polypeptides.  
66 different peptide antibiotics are elaborated by strains of Bacillus subtilis and 23 are products of Bacillus brevis. 
Polymyxin and the closely related colistin, bacitracin, the tyrothricin complex (linear gramicidin plus tyrocidine), 
and gramicidin S have been used, to some extent, for antibacterial therapy. Most of the peptide antibiotics produced 
by bacilli are active against gram-positive bacteria; however, compounds such as polymyxin, colistin, and circulin 
exhibit activity almost exclusively upon gram-negative forms, whereas bacillomycin, mycobacillin, and fungistatin 
are effective agents against molds and yeasts[10]. 
 
The Bacillus sp. showed inhibitory effect on mycobacterial growth of Mycobacterium smegmatis and 
Mycobacterium aurum (Non Tuberculosis Mycobacteria)[8]. The strain of  B. pumilus capable of inhibit 
mycobacterial growth (M. smegmatis, M. aurum A+ and M. bovis BCG) through the action of a protein 
metabolite[11].  
 
4. Conclusion 
 KJ950453.1| Bacillus sp. QW13 
 KJ534473.1| Bacillus altitudinis strain RRD69 
 KF668462.1| Bacillus stratosphericus strain IHB B 6832 
 AB851799 EKJP9 isolate
 KJ733984.1| Bacillus sp. KT4 
 KJ733996.1| Bacillus sp. KT72 
 KJ716453.1| Bacillus altitudinis strain VIT-JPAN 
 KF441699.1| Bacillus sp. 7B-769 
 KJ756332.1| Bacillus pumilus strain SWFU06 
 KJ526890.1| Bacillus pumilus strain HT-Z41 
 KJ575038.1| Bacillus aerophilus strain NIOT-Ch-27 
 KJ659072.1| Bacillus sp. SAUK10-3 
 KJ534597.1| Bacillus altitudinis strain A3-H3 
 KJ197180.1| Bacillus pumilus strain F2 
 KJ197179.1| Bacillus pumilus strain LH-Ka10 
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The  EKJP9 had antimycobacterial activity that can inhibit the growth of MDR TB bacteria with inhibitory growth 
zone and with extract of EKJP9 75%. Isolate EKJP9 identified as Bacillus sp. based on accesion number AB851799 
by DNA Data Bank of Japan. 
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